Episode 347: ESMO 2024 - DV + Pembro in Urothelial Cancer

By The Uromigos - Last Updated: September 17, 2024

Matt Galsky describes his ESMO 2024 abstract of disitimab vedotin + pembrolizumab in bladder cancer.

Post Tags:Uromigos-Bladder CancerUromigos-ESMO
Advertisement

Related Podcasts

Episode 350: ESMO 2024 - NIAGRA
Uromigos-Bladder Cancer
Episode 349: ESMO 2024 - Uromigos Japan!!
Uromigos-ESMO
Episode 348: ESMO 2024 - UpFrontPSMA
Uromigos-ESMO
Episode 346: ESMO 2024 - PEACE-3: Enza/Radium-223 vs Enza in mCRPC
Uromigos-ESMO
Episode 345: ESMO 2024 - SUNNIFORECAST: Ipi/Nivo vs SOC in Non-clear Cell RCC
Uromigos-ESMO
Advertisement
Advertisement

  • 630 Madison Ave.

    Manalapan, NJ 07726

    • About

    About Us

    Contributors and Partners

    Editorial Policy

    Advertising

    Connect

    eNewsletters

    Calendar

    Contact Us

    Contribute

    Our Network

    MashupMD

    Cancer Nursing Today

    Urban Health Today

    Blood Cancers Today

    DocWire News

    © 2024 Mashup Media, LLC. All rights reserved.

    Terms of Use | Privacy Policy